{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:02:29Z","timestamp":1790636549485,"version":"4.1.0"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T00:00:00Z","timestamp":1560729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0218561","type":"journal-article","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:32:19Z","timestamp":1560792739000},"page":"e0218561","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer\u2019s disease"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-6455","authenticated-orcid":true,"given":"Nina","family":"Schultz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin","family":"Byman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"N\u00e4gga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-1801","authenticated-orcid":true,"given":"Malin","family":"Wennstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer's neurodegeneration","volume":"28","author":"BV Zlokovic","year":"2005","journal-title":"Trends Neurosci"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"C. Iadecola","year":"2004","journal-title":"Nat Rev Neurosci"},{"issue":"Suppl 2","key":"ref3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1159\/000049150","article-title":"Small vessel disease and Alzheimer's dementia: pathological considerations","volume":"13","author":"RN Kalaria","year":"2002","journal-title":"Cerebrovasc Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"S Janelidze","year":"2017","journal-title":"Neurobiol Aging"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"A Montagne","year":"2015","journal-title":"Neuron"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(83)90157-0","article-title":"Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia","volume":"60","author":"I Alafuzoff","year":"1983","journal-title":"J Neurol Sci"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors","volume":"81","author":"K Blennow","year":"1990","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","article-title":"Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis","volume":"6","author":"R Craig-Schapiro","year":"2011","journal-title":"PLoS One"},{"issue":"Pt 5","key":"ref9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/BST0331041","article-title":"Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?","volume":"33","author":"GJ Biessels","year":"2005","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","article-title":"Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study","volume":"1","author":"LG Exalto","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref11","article-title":"Amylin alters human brain pericyte viability and NG2 expression","author":"N Schultz","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"issue":"22","key":"ref12","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/0024-3205(95)02197-Q","article-title":"Permeability of the blood-brain barrier to amylin","volume":"57","author":"WA Banks","year":"1995","journal-title":"Life Sci"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: A second amyloid in Alzheimer disease?","volume":"74","author":"K Jackson","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/CIRCRESAHA.111.258285","article-title":"Hyperamylinemia contributes to cardiac dysfunction in obesity and diabetes: a study in humans and rats","volume":"110","author":"S Despa","year":"2012","journal-title":"Circ Res"},{"issue":"7","key":"ref15","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"TA Lutz","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1111\/ejn.12672","article-title":"The role of the area postrema in the anorectic effects of amylin and salmon calcitonin: behavioral and neuronal phenotyping","volume":"40","author":"FE Braegger","year":"2014","journal-title":"Eur J Neurosci"},{"key":"ref17","article-title":"Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease","author":"H Zhu","year":"2014","journal-title":"Mol Psychiatry"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neurobiolaging.2013.10.076","article-title":"Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition","volume":"35","author":"BL Adler","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JAD-140210","article-title":"Positive association between plasma amylin and cognition in a homebound elderly population","volume":"42","author":"WQ Qiu","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","article-title":"Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels","volume":"69","author":"N Schultz","year":"2018","journal-title":"Neurobiol Aging"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, islet amyloid, and diabetes mellitus","volume":"91","author":"P Westermark","year":"2011","journal-title":"Physiol Rev"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5002305","article-title":"Amylin deposition in the kidney of patients with diabetic nephropathy","volume":"72","author":"W Gong","year":"2007","journal-title":"Kidney Int"},{"issue":"3","key":"ref23","first-page":"834","article-title":"In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease","volume":"185","author":"ME Oskarsson","year":"2015","journal-title":"Am J Pathol"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"928","DOI":"10.2174\/1567205011666141107124538","article-title":"Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease","volume":"11","author":"JN Fawver","year":"2014","journal-title":"Curr Alzheimer Res"},{"issue":"3","key":"ref25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis","volume":"15","author":"B Olsson","year":"2016","journal-title":"Lancet Neurol"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1177\/0271678X16657093","article-title":"Amylin alters human brain pericyte viability and NG2 expression","volume":"37","author":"N Schultz","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1113\/jphysiol.1976.sp011267","article-title":"Review lecture. The blood-brain barrier","volume":"255","author":"H. Davson","year":"1976","journal-title":"J Physiol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/ana.23648","article-title":"The blood-brain barrier in health and disease","volume":"72","author":"R. Daneman","year":"2012","journal-title":"Ann Neurol"},{"issue":"51","key":"ref30","doi-asserted-by":"crossref","first-page":"32916","DOI":"10.1074\/jbc.271.51.32916","article-title":"Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma","volume":"271","author":"AL Biere","year":"1996","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fnagi.2013.00038","article-title":"Lessons from two prevalent amyloidoses-what amylin and Abeta have in common","volume":"5","author":"J Gotz","year":"2013","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/ggi.12147","article-title":"Serum levels of albumin-amyloid beta complexes are decreased in Alzheimer's disease","volume":"14","author":"K Yamamoto","year":"2014","journal-title":"Geriatr Gerontol Int"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neuropharm.2017.03.030","article-title":"Amylin receptor ligands reduce the pathological cascade of Alzheimer's disease","volume":"119","author":"H Zhu","year":"2017","journal-title":"Neuropharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0218561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:51:22Z","timestamp":1588971082000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0218561"}},"subtitle":[],"editor":[{"given":"Stephen D.","family":"Ginsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0218561","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]}}}